assets.us.sumitomo-pharma.com
AMAZON-02, US


Seen 3 times between September 15th, 2023 and October 17th, 2023.


Live Screenshot Hover to expand

Attention: This is a live snapshot of this website, we do not host or control it!

No direct hits
Nothing is hosted on this domain

Incoming hits
Summary of pages that talked to this domain

ASNs AS16509 | 1x AS209242 | 1x AS54113 | 1x

IPs 23.185.0.2 | 1x 141.193.213.20 | 1x 2600:9000:2251:fa00:e:732c:1680:93a1 | 1x

Domains enzyvant.com | 1x www.sunovion.com | 1x www.urovant.com | 1x

Countries US | 3x

Recent scans (3 total) Show all

URL Age
www.urovant.com/privacy-policy?utm_source=US-VBGN-2100255&utm_medium=email&ut... a year
enzyvant.com a year
www.sunovion.com a year

Disclaimer

The websites, domains, and other information displayed on this page are not managed by urlscan. Each website and its contents are solely the responsibility of their respective owners. urlscan can remove specific website scans from our platform, but urlscan does not bear responsibility for their content. If you have been a victim of fraud by any of the websites listed, please contact your local law enforcement to report it.

Related screenshots
Screenshots of pages that talked to this domain

DNS recordsRetrieved via DNS ANY query

CNAME assets.us.sumitomo-pharma.com.sunovion.net

Registration information

Created February 8th, 2021
Updated August 1st, 2024
Registrar 1API GmbH

WHOIS for assets.us.sumitomo-pharma.com

Domain Name: SUMITOMO-PHARMA.COM
Registry Domain ID: 2589954529_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1api.net
Registrar URL: http://www.1api.net
Updated Date: 2024-08-01T08:36:09Z
Creation Date: 2021-02-08T00:10:05Z
Registrar Registration Expiration Date: 2026-02-08T00:10:05Z
Registrar: 1API GmbH
Registrar IANA ID: 1387
Registrar Abuse Contact Email: abuse@1api.net
Registrar Abuse Contact Phone: +49.68949396x850
Domain Status: clientTransferProhibited - http://www.icann.org/epp#clientTransferProhibited
Registry Registrant ID: 
Registrant Name: Domain Administrator
Registrant Organization: Sumitomo Dainippon Pharma Co., Ltd.
Registrant Street: 2-6-8 Dosho-machi, Chuo-ku
Registrant City: Osaka-shi
Registrant State/Province: Osaka
Registrant Postal Code: 541-0045
Registrant Country: JP
Registrant Phone: +81.662037011
Registrant Phone Ext: 
Registrant Fax: 
Registrant Fax Ext: 
Registrant Email: dommaster@mark-i.jp
Registry Admin ID: 
Admin Name: Domain Administrator
Admin Organization: Mark-i Inc.
Admin Street: 8F Akasaka Tameike Tower, 2-17-7 Akasaka
Admin City: Minato-ku
Admin State/Province: Tokyo
Admin Postal Code: 107-0052
Admin Country: JP
Admin Phone: +81.368629956
Admin Phone Ext: 
Admin Fax: +81.368629931
Admin Fax Ext: 
Admin Email: dommaster@mark-i.jp
Registry Tech ID: 
Tech Name: Domain Administrator
Tech Organization: Mark-i Inc.
Tech Street: 8F Akasaka Tameike Tower, 2-17-7 Akasaka
Tech City: Minato-ku
Tech State/Province: Tokyo
Tech Postal Code: 107-0052
Tech Country: JP
Tech Phone: +81.368629956
Tech Phone Ext: 
Tech Fax: +81.368629931
Tech Fax Ext: 
Tech Email: dommaster@mark-i.jp
Name Server: dns-b.iij.ad.jp
Name Server: dns-c.iij.ad.jp
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System:
http://wdprs.internic.net/
>>> Last update of WHOIS database: 2024-12-25T23:54:20Z <<<

For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.

; This data is provided for information purposes, and to assist persons
; obtaining information about or related to domain name registration
; records. We do not guarantee its accuracy.
; By submitting a WHOIS query, you agree that you will use this data
; only for lawful purposes and that, under no circumstances, you will
; use this data to
; 1) allow, enable, or otherwise support the transmission of mass
;    unsolicited, commercial advertising or solicitations via E-mail
;    (spam); or
; 2) enable high volume, automated, electronic processes that apply
;    to this WHOIS server.
; These terms may be changed without prior notice.
; By submitting this query, you agree to abide by this policy.